TXG 8-K: SEC filing

10x Genomics

Filed with the SEC on Nov 5, 2026 · accession 0001628280-26-071025

TXG filed a 8-K (current report) with the SEC on Nov 5, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

Summary of the filing

10x Genomics filed a routine Form 8-K cover page with no substantive corporate event disclosed.

For details, click here →How to read a 8-K →

Key details

Registrant10x Genomics, Inc.

✦ Ask GOAX AI about this filing — what it means for TXG, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for TXG?

Click here

Frequently asked questions

What did TXG file with the SEC on Nov 5, 2026?

TXG filed a 8-K (SEC filing). 10x Genomics filed a routine Form 8-K cover page with no substantive corporate event disclosed.

How do I read a 8-K?

A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

Other TXG SEC filings

Get alerts when TXG files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days

TXG overview TXG analysis TXG news Latest SEC filings